SE8203053L - Cysteinderivat i form av disulfid - Google Patents

Cysteinderivat i form av disulfid

Info

Publication number
SE8203053L
SE8203053L SE8203053A SE8203053A SE8203053L SE 8203053 L SE8203053 L SE 8203053L SE 8203053 A SE8203053 A SE 8203053A SE 8203053 A SE8203053 A SE 8203053A SE 8203053 L SE8203053 L SE 8203053L
Authority
SE
Sweden
Prior art keywords
pct
image
date
sec
disulfid
Prior art date
Application number
SE8203053A
Other languages
English (en)
Other versions
SE447379B (sv
Inventor
T Iso
M Oya
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of SE8203053L publication Critical patent/SE8203053L/sv
Publication of SE447379B publication Critical patent/SE447379B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/12—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36—Seven-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SE8203053A 1980-09-20 1982-05-14 Vissa disulfider SE447379B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55131349A JPS5756454A (en) 1980-09-20 1980-09-20 Disulfide type cysteine derivative

Publications (2)

Publication Number Publication Date
SE8203053L true SE8203053L (sv) 1982-05-14
SE447379B SE447379B (sv) 1986-11-10

Family

ID=15055849

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8203053A SE447379B (sv) 1980-09-20 1982-05-14 Vissa disulfider

Country Status (13)

Country Link
US (1) US4517123A (sv)
JP (1) JPS5756454A (sv)
KR (1) KR880000041B1 (sv)
AU (1) AU7590081A (sv)
BE (1) BE890399A (sv)
CA (1) CA1162188A (sv)
DE (1) DE3152362C2 (sv)
ES (1) ES8303316A1 (sv)
FR (1) FR2490637A1 (sv)
GB (1) GB2096145B (sv)
IT (1) IT1138226B (sv)
SE (1) SE447379B (sv)
WO (1) WO1982001000A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326326B1 (en) * 1988-01-25 1993-01-07 Santen Pharmaceutical Co., Ltd. Cysteine derivatives
US5041435A (en) * 1988-08-13 1991-08-20 Santen Pharmaceutical Co., Ltd. Cyclic sulfur-containing compounds
US5081307A (en) * 1989-07-14 1992-01-14 Kawaguchi Chemical Co., Ltd. Process for preparing 2,2-dimethoxy-2-phenylacetophenone
JP2720217B2 (ja) * 1989-12-05 1998-03-04 参天製薬株式会社 含硫黄アミノ酸誘導体
US5175256A (en) * 1990-09-28 1992-12-29 Neorx Corporation Protein labeling reagents
JP2843955B2 (ja) * 1992-08-01 1999-01-06 参天製薬株式会社 抗白内障剤
US5670545A (en) * 1996-02-09 1997-09-23 Board Of Regents Of The University Of Colorado Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species
US10294569B2 (en) 2017-10-06 2019-05-21 Rohm And Haas Electronic Materials Llc Stable electroless copper plating compositions and methods for electroless plating copper on substrates
US10655227B2 (en) 2017-10-06 2020-05-19 Rohm And Haas Electronic Materials Llc Stable electroless copper plating compositions and methods for electroless plating copper on substrates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5271928A (en) * 1975-12-11 1977-06-15 Sony Corp Receiving and recording unit of tv signals
JPS535112A (en) * 1976-03-08 1978-01-18 Santen Pharmaceutical Co Ltd New cysteine derivatives
JPS545916A (en) * 1977-06-17 1979-01-17 Santen Pharmaceutical Co Ltd Novel cystein derivative
JPS6058908B2 (ja) * 1978-10-11 1985-12-23 参天製薬株式会社 システイン誘導体
JPS6011888B2 (ja) * 1978-10-11 1985-03-28 参天製薬株式会社 リウマチ疾患治療薬

Also Published As

Publication number Publication date
WO1982001000A1 (en) 1982-04-01
KR830007539A (ko) 1983-10-21
JPS6143350B2 (sv) 1986-09-26
SE447379B (sv) 1986-11-10
GB2096145A (en) 1982-10-13
US4517123A (en) 1985-05-14
IT8124057A0 (it) 1981-09-21
FR2490637B1 (sv) 1984-12-14
DE3152362T1 (sv) 1982-10-07
BE890399A (fr) 1982-01-18
DE3152362C2 (de) 1986-08-28
ES505628A0 (es) 1983-02-01
CA1162188A (en) 1984-02-14
FR2490637A1 (fr) 1982-03-26
ES8303316A1 (es) 1983-02-01
GB2096145B (en) 1984-05-02
IT1138226B (it) 1986-09-17
JPS5756454A (en) 1982-04-05
AU7590081A (en) 1982-04-14
KR880000041B1 (ko) 1988-02-20

Similar Documents

Publication Publication Date Title
US4302465B1 (sv)
ES2126068T3 (es) Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene.
CO4770945A1 (es) Composiciones orales antiplaca que contienen fenol alquila- tado antibacterial
SE8603099D0 (sv) Distamycin derivatives and process for their preparation
DK57281A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater eller syreadditionssalte deraf
IE45576L (en) Analgesic tetrapeptides and pentapeptides
SE8203053L (sv) Cysteinderivat i form av disulfid
ES2062443T3 (es) Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
PT89082A (pt) Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico
ATE115980T1 (de) Neue thyroninderivate.
LV10098A (lv) Metilpiperazinazepina atvasinajumi to iegusana un lietosana
MX9301721A (es) Derivados, composiciones de carbinol de bis-arilo sin puente, y metodos de uso.
DE3268541D1 (en) Benzodioxane-imidazoline compounds, their preparation and use
SE8107806L (sv) N-substituerade iminodiettiksyror
IL67564A (en) 7-heteroaryl-(1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them
ES2069881T3 (es) Derivado de 15-desoxiprostaglandina.
SE8400629L (sv) Basiska oximetrar
SE7712447L (sv) Sett att framstella nya bensofenonderivat
MX169275B (es) Proceso para la preparacion de derivados de 6-deoxi guanidina
CO4770982A1 (es) Nuevas formulaciones
GB997011A (en) Improvements in or relating to thraxanthene derivatives
GR75376B (sv)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8203053-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8203053-7

Format of ref document f/p: F